Prognostic analysis demonstrates that elevated interleukin-6 and C-reactive protein predict impaired survival in metastatic colorectal cancer, indicating independent biomarker value.
High baseline serum consentrations of IL-6 or CRP were associated with impaired prognosis in mCRC. IL-6 and CRP give independent prognostic information in addition to RAS and BRAF mutation status.
No takes yet. Share an insight, caveat, or question.
Thomsen et al. (2016) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: